Literature DB >> 15676280

Ancient repeated DNA elements and the regulation of the human frataxin promoter.

Eriko Greene1, Ali Entezam, Daman Kumari, Karen Usdin.   

Abstract

Friedreich ataxia results from frataxin insufficiency caused by repeat expansion in intron 1 of the frataxin gene. Since the coding sequence is unchanged, the potential exists to ameliorate symptoms by increasing frataxin promoter activity. We therefore defined the minimal frataxin promoter in humans. Despite the fact that frataxin is an essential gene, its promoter is not well conserved in mammals, in part because it has been the frequent target of retroelement insertions. Most of the activity of the human frataxin promoter can be attributed to these retroelements, illustrating how these elements, considered parasitic by some, have been co-opted to drive critical genes. Individuals with the milder French Acadian form and those with the classic form of the disease have no biologically relevant sequence differences in the promoter or 3' UTR, suggesting that some other region of the gene, perhaps the repeat itself, is responsible for the difference in disease severity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15676280     DOI: 10.1016/j.ygeno.2004.10.013

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  13 in total

1.  Repeat expansion affects both transcription initiation and elongation in friedreich ataxia cells.

Authors:  Daman Kumari; Rea Erika Biacsi; Karen Usdin
Journal:  J Biol Chem       Date:  2010-12-02       Impact factor: 5.157

2.  Transcriptional profiling of isogenic Friedreich ataxia neurons and effect of an HDAC inhibitor on disease signatures.

Authors:  Jiun-I Lai; Daniel Nachun; Lina Petrosyan; Benjamin Throesch; Erica Campau; Fuying Gao; Kristin K Baldwin; Giovanni Coppola; Joel M Gottesfeld; Elisabetta Soragni
Journal:  J Biol Chem       Date:  2018-12-14       Impact factor: 5.157

Review 3.  Friedreich ataxia: molecular mechanisms, redox considerations, and therapeutic opportunities.

Authors:  Renata Santos; Sophie Lefevre; Dominika Sliwa; Alexandra Seguin; Jean-Michel Camadro; Emmanuel Lesuisse
Journal:  Antioxid Redox Signal       Date:  2010-09-01       Impact factor: 8.401

Review 4.  Small molecules affecting transcription in Friedreich ataxia.

Authors:  Joel M Gottesfeld
Journal:  Pharmacol Ther       Date:  2007-08-09       Impact factor: 12.310

5.  Expression of human frataxin is regulated by transcription factors SRF and TFAP2.

Authors:  Kuanyu Li; Anamika Singh; Daniel R Crooks; Xiaoman Dai; Zhuangzhuang Cong; Liang Pan; Dung Ha; Tracey A Rouault
Journal:  PLoS One       Date:  2010-08-20       Impact factor: 3.240

Review 6.  Intracellular iron transport and storage: from molecular mechanisms to health implications.

Authors:  Elizabeth L MacKenzie; Kenta Iwasaki; Yoshiaki Tsuji
Journal:  Antioxid Redox Signal       Date:  2008-06       Impact factor: 8.401

7.  Long range regulation of human FXN gene expression.

Authors:  Novita Puspasari; Simone M Rowley; Lavinia Gordon; Paul J Lockhart; Panos A Ioannou; Martin B Delatycki; Joseph P Sarsero
Journal:  PLoS One       Date:  2011-07-08       Impact factor: 3.240

8.  Inhibition of the function of class IIa HDACs by blocking their interaction with MEF2.

Authors:  Nimanthi Jayathilaka; Aidong Han; Kevin J Gaffney; Raja Dey; Jamie A Jarusiewicz; Kaori Noridomi; Michael A Philips; Xiao Lei; Ju He; Jun Ye; Tao Gao; Nicos A Petasis; Lin Chen
Journal:  Nucleic Acids Res       Date:  2012-03-06       Impact factor: 16.971

9.  Defining Transcription Regulatory Elements in the Human Frataxin Gene: Implications for Gene Therapy.

Authors:  Jixue Li; Yanjie Li; Jun Wang; Trevor J Gonzalez; Aravind Asokan; Jill S Napierala; Marek Napierala
Journal:  Hum Gene Ther       Date:  2020-07-13       Impact factor: 4.793

10.  Repeat-induced epigenetic changes in intron 1 of the frataxin gene and its consequences in Friedreich ataxia.

Authors:  Eriko Greene; Lata Mahishi; Ali Entezam; Daman Kumari; Karen Usdin
Journal:  Nucleic Acids Res       Date:  2007-05-03       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.